As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

By registering you consent to the collection and use of your information to provide the products and services you have ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Officials said they began distributing more than 2 million pieces of personal protective equipment in late May, four months ...

Michelle Peters Wellington announced Thursday that she has joined Vistagen Therapeutics as VP of communications. Wellington ...

If you bring a baby into the Hurley Children’s Center clinic in downtown Flint, Michigan, Mona Hanna will find you. The ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

By leveling up their streaming campaigns, advertisers can achieve big lifts in awareness and sales of their medications among ...

BioNTech is shelling out $800 million upfront to acquire China-based Biotheus in a move that would give it access to a ...

In 2022, Maryland lawmakers passed the Abortion Care Access Act, expanding the type of medical care nurse practitioners, ...

Several app researchers and users report seeing the free version of X’s AI chatbot, Grok, being made available to people ...

In a post on his Instagram account, Schwarzenegger said he is eager to join Zimmer Biomet in the unique role and utilize his ...